Sugi Holdings Co.,Ltd.

7649.T
Pharmaceutical Retailers
2026/04/10 Updated
Market Cap: $4.1B (¥650.2B)
Stock Price: $22.60 (¥3,593)
Exchange Rate: 1 USD = ¥158.98

Fiscal Year Ending February 2026 Financial Summary [Japanese GAAP] (Consolidated)

For the fiscal year ending February 2026, consolidated net sales amounted to 1,010,336 million yen (15.1% increase YoY), operating income was 48,568 million yen (14.1% increase YoY), and net income attributable to owners of parent was 44,982 million yen (75.1% increase YoY). A stock split is scheduled for September 1, 2026.

Importance:
Page Updated: April 9, 2026
IR Disclosure Date: April 9, 2026

Key Figures

  • Net Sales: 1,010,336 million yen (15.1% increase YoY)
  • Net Income Attributable to Owners of Parent: 44,982 million yen (75.1% increase YoY)
  • Number of Stores: 2,321 stores (110 new openings, 46 closures)

AI要約

Performance Overview

For the fiscal year ending February 2026, consolidated results were net sales of 1,010,336 million yen (15.1% increase YoY), operating income of 48,568 million yen (14.1% increase YoY), ordinary income of 50,062 million yen (19.2% increase YoY), and net income attributable to owners of parent of 44,982 million yen (75.1% increase YoY). Despite a challenging environment in the drugstore and dispensing sectors, sales and profits expanded through dominant store openings and renovations in the Kanto, Chubu, and Kansai regions, enhanced promotion activities utilizing digital transformation (DX), and strengthening specialized expertise in the dispensing field. The number of stores increased to 2,321 with 110 new openings and 46 closures.

Financial Position and Cash Flow Status

Total assets reached 614.493 billion yen (an increase of 119.377 billion yen from the previous fiscal year), net assets were 290.474 billion yen (an increase of 39.770 billion yen), and the equity ratio declined to 47.3%. Cash flow from operating activities amounted to 86.779 billion yen (134.9% increase YoY), cash flow used in investing activities was 69.639 billion yen, and cash flow from financing activities was 41.213 billion yen. Cash and cash equivalents increased to 111.150 billion yen.

Outlook and Medium-Term Management Plan

The new 5-year medium-term management plan starting from the fiscal year ending February 2027 targets net sales exceeding 1.6 trillion yen, operating income margin above 5.5%, and ROE over 15% by the fiscal year ending February 2031. The plan aims to promote DX, expand business through M&A, and maintain financial soundness. Seki Yakuhin Co., Ltd. is scheduled to become a consolidated subsidiary on September 1, 2026, with a focus on synergy creation. A stock split will also be conducted on the same date to broaden the investor base.

Dividend Policy

The annual dividend for the current term is 35 yen (15 yen interim, 20 yen year-end), with the same dividend planned for the next term. Considering the stock split in September 2026, the dividend per share will be 15 yen interim and 10 yen year-end. The basic policy combines stable dividends with shareholder returns through share buybacks.

Net Sales Trend (Million Yen)

Operating Income Trend (Million Yen)

Net Income Attributable to Owners of Parent Trend (Million Yen)

Annual Dividend Trend (Yen)

Number of Stores Trend (Stores)

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.